Connection
Mandy Sakamoto to B7-H1 Antigen
This is a "connection" page, showing publications Mandy Sakamoto has written about B7-H1 Antigen.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.162 |
|
|
|
-
Sakamoto M, Jimeno A. Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer. Drugs Today (Barc). 2023 Mar; 59(3):169-177.
Score: 0.162